Comparison of nifedipine, propranolol and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowings in angina pectoris.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  American Journal of Cardiology

• Publication date

  1989-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9149(89)90417-7PMID 2773786
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regression of coronary atherosclerosis: is it possible?

  1988cited by this paper
• Strategies to reduce risk factors in hypertensive patients who smoke.

  1988cited by this paper
• Prediction of risk of anterior myocardial infarction by lesion severity and measurement method of stenoses in the left anterior descending coronary distribution: a CASS Registry Study.

  1988cited by this paper
• The cardiovascular pathology of smoking.

  1988cited by this paper
• Nifedipine and angina pectoris. Short-term changes in quantitative coronary angiography with nifedipine and clinical response to treatment in effort-induced, mixed, and spontaneous angina pectoris.

  1988cited by this paper
• The effects of beta-adrenergic blocking agents on atherosclerosis and its complications.

  1987cited by this paper
• Double-blind trial of the long-term effects of acebutolol and propranolol on serum lipoproteins in patients with stable angina pectoris.

  1987cited by this paper
• The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study.

  1987cited by this paper
• Progression of coronary atherosclerotic disease assessed by cinevideodensitometry: relation to clinical risk factors.

  1986cited by this paper
• On a possible role for calcium antagonists in atherosclerosis. A personal view.

  1986cited by this paper
• Importance of risk factors in the angiographic progression of coronary artery disease.

  1986cited by this paper
• Angiographic evolution of coronary artery morphology in unstable angina.

  1986cited by this paper
• Cardiovascular Protection by Calcium Antagonists

  1985cited by this paper
• Factors associated with progression of coronary artery disease in patients with normal or minimally narrowed coronary arteries.

  1985cited by this paper
• Atherosclerosis, calcium, and calcium antagonists.

  1985cited by this paper
• Digital quantification eliminates intraobserver and interobserver variability in the evaluation of coronary artery stenosis.

  1985cited by this paper
• Modification of experimental atherosclerosis by calcium-channel blockers.

  1985cited by this paper
• Prognostic significance of progression of coronary artery disease.

  1985cited by this paper
• Arteriographic assessment of coronary atherosclerosis. Review of current methods, their limitations, and clinical applications.

  1982cited by this paper
• Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine.

  1981cited by this paper
• The Anatomic Evolution of Coronary Artery Disease Demonstrated by Coronary Arteriography in 256 Nonoperated Patients

  1981cited by this paper
• Progression of Coronary Atherosclerosis

  1981cited by this paper
• Cardiovascular protection by Ca antagonists.

  1980cited by this paper
• Dilation of coronary artery stenoses after isosorbide dinitrate in man.

  1980cited by this paper
• Quantitative coronary arteriography. Coronary anatomy of patients with unstable angina pectoris reexamined 1 year after optimal medical therapy.

  1979cited by this paper
• Sensitization of Isolated Canine Coronary Arteries to Calcium Ions after Exposure to Cholesterol

  1979cited by this paper
• Progression of Coronary Artery Disease: A Clinical Arteriographic Study

  1973cited by this paper

• Propranolol hydrochloride induces neurodevelopmental toxicity and locomotor disorders in zebrafish larvae.

  2022cites this paper
• Alteration of the soluble guanylate cyclase system in coronary arteries of high cholesterol diet‐fed rabbits

  2021cites this paper
• Propranolol suppresses infantile hemangioma cell proliferation and promotes apoptosis by upregulating miR-125b expression

  2019cites this paper
• Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Recommendations for Antihypertensive Therapy.

  2017cites this paper
• Propranolol represses infantile hemangioma cell growth through the β2-adrenergic receptor in a HIF-1α-dependent manner.

  2015cites this paper
• Direct anti-atherosclerotic therapy preventing intracellular cholesterol retention

  2013cites this paper
• Anti-atherosclerotic Drugs from Natural Products

  2013cites this paper
• Direct anti-atherosclerotic therapy; development of natural anti-atherosclerotic drugs preventing cellular cholesterol retention.

  2013cites this paper
• Use of Natural Products for Direct Anti-Atherosclerotic Therapy

  2013cites this paper
• Factors underlying regression of coronary atheroma with potent statin therapy.

  2013cites this paper
• Hypertension Treatment and Prevention of New Atherosclerotic Plaque Formation

  2012cites this paper
• Nifedipine inhibits hypoxia induced transvascular leakage through down regulation of NFkB.

  2012cites this paper
• Use of Cell Culture for Optimisation of Direct Antiatherogenic Therapy with Verapamil

  2012cites this paper
• Secondary and Tertiary Prevention with Calcium Antagonists in Coronary Artery Disease

  2012cites this paper
• Effect of a dihydropyridine-type calcium channel blocker on vascular remodeling after experimental balloon angioplasty.

  2011cites this paper
• Bewegungstherapie bei koronarer Herzkrankheit

  2010cites this paper
• Calciumantagonisten in der Kontroverse: Gibt es eine rationale Differentialtherapie?1

  2008cites this paper
• -Blockers and Progression of Coronary Atherosclerosis: Pooled Analysis of 4 Intravascular Ultrasonography Trials

  2007cites this paper
• Synergistic Effects of Calcium Antagonists and Statins on Endothelial Function

  2007cites this paper
• The Anglo‐Scandinavian Cardiac Outcomes Trial – Blood Pressure Lowering Arm

  2006cites this paper
• A Randomized, Double‐Blind Trial Comparing the Effects of Amlodipine Besylate/Benazepril HCl vs Amlodipine on Endothelial Function and Blood Pressure

  2006cites this paper
• Comment Calcium Channel Blockers and Progression of Coronary Artery Disease

  2005cites this paper
• 11-60 / 3-Blockers , Plasma Lipids , and Coronary Heart Disease

  2005cites this paper
• Radiographically detectable calcium and atherosclerosis: the connection and its exploitation

  2005cites this paper
• Divergent Action of Calcium Channel Blockers on ATP-Binding Cassette Protein Expression

  2005cites this paper
• Evolution of Coronary Atherosclerosis

  2005cites this paper
• Effect of nifedipine on endothelial function in normotensive smokers: potential contribution of increase in circulating hepatocyte growth factor

  2004cites this paper
• Role of calcium channel blocking agents in the prevention of atherosclerosis

  2004cites this paper
• Efectos "pleiotropicos" de los antagonistas del calcio

  2004cites this paper
• Calcium antagonists.

  2004cites this paper
• Calcium Antagonists and Atherosclerosis Protection in Hypertension

  2003cites this paper
• Effects of calcium channel blockers on atherosclerosis: new insights

  2002cites this paper
• Antiatherosclerotic effects of calcium channel blockers.

  2002cites this paper
• Nifedipine Prevents Apoptosis of Endothelial Cells Induced By Oxidized Low-density Lipoproteins

  2002cites this paper
• Effect of calcium channel blockers on proteoglycan synthesis by vascular smooth muscle cells and low density lipoprotein--proteoglycan interaction.

  2001cites this paper
• The calcium inhibitor SR33805 reduces intimal formation following injury of the porcine carotid artery.

  2001cites this paper
• [The anti-atherogenic mechanism of action of physical training in patients with coronary heart disease].

  2001cites this paper
• Coronary benefits of calcium antagonist therapy for patients with hypertension.

  2001cites this paper
• Antiatherogene Wirkungsmechanismen des körperlichen Trainings bei Patienten mit koronarer Herzkrankheit

  2001cites this paper
• End organ protection by calcium‐channel blockers

  2001cites this paper
• Michael Motro and Joseph Shemesh in Hypertensive Patients Compared With Diuretics Calcium Channel Blocker Nifedipine Slows Down Progression of Coronary Calcification

  2001cites this paper
• Calcium Channel Blocker Nifedipine Slows Down Progression of Coronary Calcification in Hypertensive Patients Compared With Diuretics

  2001cites this paper
• Efficacy, Tolerability and Influence on "Quality of Life" of Nifedipine GITS versus Amlodipine in Elderly Patients with Mild-moderate Hypertension

  2001cites this paper
• Overview of the prospective randomized evaluation of the vascular effects of Norvasc (amlodipine) trial: PREVENT.

  2000cites this paper
• Calcium Antagonists and Ischemic Heart Disease

  2000cites this paper
• Intermediate coronary artery stenosis: evidence-based decisions in interventions to avoid the oculostenotic reflex

  2000cites this paper
• Cholesterol, Triglycerides, and the Treatment of Hyperlipidemias

  2000cites this paper
• Nifedipine suppresses neointimal thickening by its inhibitory effect on vascular smooth muscle cell growth via a MEK‐ERK pathway coupling with Pyk2

  2000cites this paper
• Current status of calcium channel blockers in patients with cardiovascular disease.

  1999cites this paper
• Kalziumantagonisten Resultate neuer Studien und ihre Bedeutung für die Praxis

  1999cites this paper
• Can calcium antagonists reverse atherosclerosis?

  1999cites this paper
• Pharmacologic effects of calcium channel blockers on restenosis.

  1999cites this paper
• The rationale of using calcium antagonists in the treatment of ischaemic heart disease

  1999cites this paper
• Can calcium antagonists reverse atherosclerosis ?

  1999influential citation
• Calcium antagonists. Results of recent studies and their significance for general practice.

  1999cites this paper
• Das koronare Gefäßendothel

  1998cites this paper
• The Effects of Antihypertensive Agents on Atherosclerosis-Related Parameters of Human Aorta Intimal Cells

  1998cites this paper
• Design and current status of ACTION: A Coronary disease Trial Investigating Outcome with Nifedipine GITS. Gastro-Intestinal Therapeutic System.

  1998cites this paper
• Clinical advantages of lipophilic dihydropyridines.

  1998cites this paper
• Issues in the performance of quantitative coronary angiography in clinical research trials

  1998cites this paper
• Proposed Synergistic Effect of Calcium Channel Blockers with Lipid-Lowering Therapy in Retarding Progression of Coronary Atherosclerosis

  1998cites this paper
• Combination of ACE inhibitors and calcium antagonists: a logical approach.

  1998cites this paper
• Calcium channel blockers in cardiac failure.

  1998cites this paper
• Ist Die Kalziumantagonistenkontroverse Gelöst?

  1998cites this paper
• [Endothelial dysfunction and nitrogen monoxide (NO; nitric oxide)].

  1997cites this paper
• Endothelial Function and Calcium Metabolism

  1997cites this paper
• A comparative study on the effects of Gemfibrozil, Diltiazem and Isosorbide dinitrate on lipid profile in patients of ischemic heart disease in India

  1997cites this paper
• Calcium antagonists and atherosclerosis.

  1997cites this paper
• Endotheliale Dysfunktion und Stickstoffmonoxid (NO; Nitric Oxide)

  1997cites this paper
• Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease?

  1997cites this paper
• Diversity of calcium antagonists.

  1997cites this paper
• Clinical promise of calcium antagonists in the angioplasty patient.

  1997cites this paper
• Evidence of multifocal activity of coronary disease in patients with acute myocardial infarction.

  1997cites this paper
• Limits of lipid-lowering therapy: the potential benefits of amlodipine as an antiatherosclerotic agent.

  1997cites this paper
• Metabolic manifestations of low-dose diuretics.

  1996cites this paper
• Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group.

  1996cites this paper
• Myocardial infarction associated with antihypertensive drug therapy.

  1996cites this paper
• Myocardial infarction associated with antihypertensive drug therapy.

  1996cites this paper
• Endothelin and calcium antagonists in the skin microcirculation of patients with coronary artery disease.

  1996cites this paper
• Calcium-channel blockers inhibit human low-density lipoprotein oxidation by oxygen radicals

  1996cites this paper
• Direct antiatherogenic effect of garlic

  1996cites this paper
• Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis

  1996cites this paper
• [Controversy over calcium antagonists: is there a rationally differentiating therapy?].

  1996cites this paper
• Age-Related Changes Affecting Atherosclerotic Risk

  1996cites this paper
• Calcium antagonists and cardiovascular prognosis: a homogeneous group?

  1996cites this paper
• Reversal of atherosclerosis with therapy: update of coronary angiographic trials.

  1996cites this paper
• Considerations on current and future trials in hypertension.

  1996cites this paper
• The calcium channel blocker controversy.

  1996cites this paper
• [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].

  1996cites this paper
• Hypocalcemia, morbidity, and mortality in end-stage renal disease.

  1996cites this paper
• Lessons from the Monitored Atherosclerosis Regression Study (MARS) and beyond: atherosclerosis progression/regression responses to therapy depend on lesion size and composition

  1996cites this paper
• Das ischämische Herz — Ursachen, Auswirkungen und Therapie

  1995cites this paper
• Effect of SR 33805 on arterial smooth muscle cell proliferation and neointima formation following vascular injury.

  1995cites this paper
• Angiotensin-converting enzyme inhibitors and calcium antagonists after acute myocardial infarction.

  1995cites this paper
• Atherosclerosis progression/regression: lipoprotein and vessel wall determinants

  1995cites this paper
• Coronary plaque disruption.

  1995cites this paper
• 12 Calcium channel blockers

  1995cites this paper
• Direct anti-atherosclerosis-related effects of garlic.

  1995cites this paper
• Atherosclerosis progression/regression: lipoprotein and vessel wall determinants.

  1995cites this paper
• The treatment of myocardial infarction.

  1995cites this paper